Anorexia: Clinical Trials

21 trials for Anorexia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed. 21 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 221Completed 21
Phase 33Completed 3
Phase 11Completed 1

Follow Anorexia: new trials by email Literature Review of Anorexia trials Research Report on Anorexia

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
ROSE-010 99 mcg, Placebo, ROSE-010 150 mcg - Obesity; Overweight
Phase 2CompletedRose Pharma Inc402024-09-262026-06-01
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
ponsegromab, Placebo for ponsegromab - Non-small Cell Lung Cancer, Pancreatic Cancer
Phase 2CompletedPfizer1872022-11-212026-06-03
Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products
Net peripheral AA appearance following ingestion of 3 selected PPF products compared to whey - Aging, Undernutrition
Phase 2CompletedUniversity College Dublin92022-03-142022-09-26
Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy
Psilocybin - Anorexia Nervosa
Phase 2CompletedUniversity of California, San Diego162021-05-012022-07-25
Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.
Mirtazapine, Megestrol - Cachexia; Cancer, Anorexia
Phase 2CompletedUniversity of Sao Paulo522019-03-262023-07-07
Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa
RM-131, Placebo - Anorexia Nervosa
Phase 2CompletedMotus Therapeutics, Inc.202012-11-012016-09-23
A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
Trazodone, Placebo - Depression
Phase 2 / Phase 3CompletedLee's Pharmaceutical Limited3822011-11-012014-10-16
DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients
DaHuang GanTsao Tang - Non-organic Loss of Appetite
Phase 2CompletedChanghua Christian Hospital42011-03-012020-02-17
Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
Olanzapine - Amyotrophic Lateral Sclerosis (ALS)
Phase 2 / Phase 3CompletedCharite University, Berlin, Germany402011-03-012024-02-14
Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
Low Dose Fish Oil, High Dose Fish Oil - Major Depressive Disorder
Phase 2 / Phase 3CompletedUniversity of Cincinnati202007-08-012016-05-27
Regimen for the Treatment of Cachexia in Subjects With NSCLC
VT-122 low dose, VT-122 high dose - Cachexia
Phase 2CompletedVicus Therapeutics372007-01-012013-01-30
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
Palonosetron - Melanoma
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center302006-11-012012-05-04
The Effects of Thalidomide on Symptom Clusters
Thalidomide, Placebo - Advanced Cancers
Phase 2CompletedM.D. Anderson Cancer Center322006-09-012013-02-04
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
Marinol (Dronabinol), Placebo - Cancer, Anorexia
Phase 2CompletedAlberta Health services802006-08-012010-02-09
Safety and Efficacy of APD356 in the Treatment of Obesity
APD356 - Obesity
Phase 2CompletedEisai Inc.4002005-06-012019-09-12
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
RC-1291 HCl - Cancer Cachexia
Phase 2CompletedHelsinn Therapeutics (U.S.), Inc802005-06-012013-09-02
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL, Megestrol acetate oral suspension 40 mg/mL - HIV Infections, Cachexia
Phase 2CompletedEndo USA Inc., a Keenova Therapeutics Company632004-12-012017-10-05
Safety and Efficacy of APD356 in the Treatment of Obesity
APD356 - Obesity
Phase 2CompletedEisai Inc.4002004-12-012019-09-12
Comparing the Effectiveness of Three Types of Therapy for the Treatment of Anorexia Nervosa in Adolescents
Family therapy (FT), Individual therapy (IT) - Eating Disorders
Phase 2CompletedUniversity of Chicago1212004-04-012016-06-20
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Infliximab; Gemcitabine - Cachexia, Pancreatic Neoplasms
Phase 2CompletedCentocor, Inc.732003-04-012011-05-17

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Cachexia (8)  ·  Weight Loss (5)  ·  Anorexia Nervosa (3)  ·  Fatigue (3)  ·  Feeding and Eating Disorders (3)  ·  Neoplasms (3)  ·  Obesity (3)  ·  Overweight (3)  ·  HIV Infections (2)  ·  Malnutrition (2)  ·  Pancreatic Neoplasms (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (21)  ·  Signs and Symptoms (21)  ·  Signs and Symptoms, Digestive (21)  ·  Body Weight (12)  ·  Body Weight Changes (10)  ·  Thinness (8)  ·  Nutrition Disorders (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Weight Loss (6)  ·  Mental Disorders (3)  ·  Neoplasms by Site (3)  ·  Nervous System Diseases (3)  ·  Overnutrition (3)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)

Interventions

Megestrol Acetate (3)  ·  lorcaserin (2)  ·  Dronabinol (1)  ·  Family Therapy (1)  ·  Fish Oils (1)  ·  Gemcitabine (1)  ·  Infliximab (1)  ·  Megestrol (1)  ·  Mirtazapine (1)  ·  Olanzapine (1)  ·  Palonosetron (1)  ·  Psilocybin (1)  ·  Thalidomide (1)  ·  Trazodone (1)  ·  glucagon-like peptide (7-37), valyl(10)- (1)

Sponsors

Eisai Inc. (2)  ·  M.D. Anderson Cancer Center (2)  ·  Alberta Health services (1)  ·  Bristol-Myers Squibb (1)  ·  Centocor, Inc. (1)  ·  Changhua Christian Hospital (1)  ·  Charite University, Berlin, Germany (1)  ·  Endo USA Inc., a Keenova Therapeutics Company (1)  ·  Helsinn Therapeutics (U.S.), Inc (1)  ·  Lee's Pharmaceutical Limited (1)  ·  Motus Therapeutics, Inc. (1)  ·  Pfizer (1)  ·  Rose Pharma Inc (1)  ·  University College Dublin (1)  ·  University of California, San Diego (1)

Countries

United States (14)  ·  Canada (2)  ·  China (2)  ·  India (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Germany (1)  ·  Hungary (1)  ·  Ireland (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  Slovakia (1)

Top investigators

Agop Y. Bedikian, MD (1)  ·  Anne Klibanski, MD (1)  ·  Benjamin LI, Ph.D. (1)  ·  Daniel Le Grange, PhD (1)  ·  Dominique Dardevet, Dr (1)  ·  Eduardo Bruera, MD (1)  ·  Giuseppe De Vito, Prof (1)  ·  Ingrid H. de Kock, MD (1)  ·  Jan Fourie, MD (1)  ·  Katy Horner, Dr (1)  ·  Nereida KC Lima, MD, PhD (1)  ·  Richard A Guarino, MD (1)

Results publications

PMID 18257397, PMID 19057523, PMID 21343383, PMID 25524795, PMID 29325236, PMID 37488291, PMID 38500292, PMID 38988455, PMID 39282907

NIH funding

2023 (1), R01MH070620 (1)